Association Between Transcatheter Aortic Valv...

Steven Nissen, MD, and Luke Laffin, MD, discuss one-year follow-up data for CTX310, a CRISPR-Cas9 gene-editing therapy targeting ANGPTL3 to treat lipid disorders. They review the sustained reductions in LDL cholesterol and triglycerides, and the potential role of one-time gene-ed ...  Show more

Steven Nissen, MD, and Ashish Sarraju, MD, discuss early clinical data on Kylo-11, a novel therapy that produced substantial reductions in lipoprotein(a) for up to one year after a single injection. Lowering lipoprotein(a), a genetically determined cardiovascular risk factor link ...  Show more

Stroke is a potentially devastating TAVR complication. In this episode, CardioNerds (Drs. Amit Goyal, Nikolaos Spilias, Ahmed Ghoneem, and Chelsea Amo-Tweneboah) discuss TAVR and stroke risk, stroke prevention strategies, and future directions with Dr. Samir Kapadia, Department c ...  Show more

Dr. Dan Ackerman talks with Dr. Luciano A. Sposato about the topic of embolic stroke of undetermined source and the controversies surrounding cardiac monitoring and anticoagulation.  Read the related article in Neurology.  Disclosures can be found at Neurology.org. 

In this week’s View, Dr. Eagle discusses the recent expert panel statement on positron emission tomography (PET) for assessment of coronary microvascular dysfunction, then looks at the impact of transcatheter mitral valve repair availability on the volume and outcomes of surgical ...  Show more

Dr. Linda Chu discusses the clinical impact of cardiac MRI T1 and T2 maps in patients with suspected cardiomyopathy with Dr. William Warnica and Dr. Kate Hanneman. Clinical Impact of Cardiac MRI T1 and T2 Parametric Mapping in Patients with Suspected Cardiomyopathy. Warnica et al ...  Show more